DJIA 17,810.06 0.00 0.00%
NASDAQ 4,712.97 0.00 0.00%
S&P 500 2,063.50 0.00 0.00%
market minute promo

The Medicines Company (NASDAQ: MDCO)



company name or ticker
Company Photos
(Click to zoom)

The Medicines Company Stock Downgraded (MDCO)

EU Review for The Medicines Co.'s Oritavancin - Analyst Blog

First Week of October 18th Options Trading For Medicines (MDCO)

After Cangrelor, The Medicines Company Gets Priority Review for New Drug

After its anti-clotting agent Cangrelor was rejected by an FDA committee, The Medicines Company sets its sights on getting approval for skin infection drug oritavancin.

The Medicines Co Posts Lower Y/Y Q4 Earnings - Analyst Blog

The Medicines Company CEO Discusses Q4 2013 Results - Earnings Call Transcript

Today's Biggest Biotech Stories: Chelsea, Novartis, and The Medicines Company

Chelsea, Novartis, and The Medicines Company could all loom large in health-care headlines this morning. Here's why.

Sector Update: Health Care

Sector Update: Healthcare Shares Flat Pre-Market; NeoGenomics Down 2% on Expected Impact of Billing

Sector Update: Healthcare Shares Flat Pre-Market; NeoGenomics Down 2% on Expected Impact of Billing Changes

The Medicines Company Discusses Q1 2014 Results (Webcast)